AJP - Heart and Circulatory Physiology, Vol 257, Issue 1 147-H156, Copyright © 1989 by American Physiological Society

ARTICLES

Mechanisms of hypoxia-induced atrial natriuretic factor release from rat hearts

R. A. Lew and A. J. Baertschi
Department of Physiology, University of Virginia School of Medicine, Charlottesville 22908.

Potential mechanisms of hypoxia-induced atrial natriuretic factor (ANF) release [A.J. Baertschi, J.M. Adams, and M.P. Sullivan. Am. J. Physiol. 255 (Heart Circ. Physiol. 24): H295-H300, 1988] were investigated in Langendorff-perfused rat hearts. The ANF release was graded with stimulus intensity; 10 min of perfusion with Krebs-Henseleit solution equilibrated with 95, 20, 10, 5, and 0% oxygen led to peak ANF levels of 140 +/- 31 (SE), 202 +/- 20, 407 +/- 76, 659 +/- 119, and 516 +/- 83% of base-line ANF (159 +/- 14 pg/ml), respectively. Hypoxia-induced release of lactate dehydrogenase and creatine kinase did not correlate with ANF release; this finding, along with other experiments, rules out tissue damage as a significant factor. Phentolamine (1.3 microM) and propranolol (0.1 microM) each reduced peak hypoxia-induced (0% O2) ANF release to 333 and 310%, respectively, whereas atropine sulfate (15 microM) had no inhibitory effect. The three antagonists combined reduced the peak hypoxia-induced ANF release to the same extent (307%) as either phentolamine or propranolol alone. Earlier (24 h) catecholamine depletion of rats with 100 mg/kg 6-hydroxydopamine also significantly reduced peak hypoxia-induced ANF release to 330%. Neither the reduction of the ANF secretory responses by these interventions nor the remaining ANF response could be attributed to changes in atrial mechanics. Therefore, these studies demonstrate that alpha- and beta-adrenergic stimulation is responsible for approximately half the hypoxia-induced ANF release from the isolated heart, whereas an as yet undefined mechanism accounts for the remainder of the response.

This article has been cited by other articles:

				D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]

				K. Tayama, S. Takamori, M. Mitsuoka, A. Hayashi, K. Tamura, H. Mifune, and K. Shirouzu Natriuretic peptides after pulmonary resection Ann. Thorac. Surg., May 1, 2002; 73(5): 1582 - 1586. [Abstract] [Full Text] [PDF]

				J. R. Klinger, L. Pietras, R. Warburton, and N. S. Hill Reduced Oxygen Tension Increases Atrial Natriuretic Peptide Release from Atrial Cardiocytes Experimental Biology and Medicine, October 1, 2001; 226(9): 847 - 853. [Abstract] [Full Text] [PDF]

				A. Baron, L. van Bever, D. Monnier, A. Roatti, and A. J. Baertschi A Novel KATP Current in Cultured Neonatal Rat Atrial Appendage Cardiomyocytes Circ. Res., October 15, 1999; 85(8): 707 - 715. [Abstract] [Full Text] [PDF]

				T. S. E. Albert, V. L. Tucker, and E. M. Renkin Atrial natriuretic peptide levels and plasma volume contraction in acute alveolar hypoxia J Appl Physiol, January 1, 1997; 82(1): 102 - 110. [Abstract] [Full Text] [PDF]